Schein Pharmaceutical Inc – ‘8-K’ for 5/3/00

On:  Thursday, 5/4/00, at 4:05pm ET   ·   For:  5/3/00   ·   Accession #:  922423-0-691   ·   File #:  1-14019

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         3     10K 
 2: EX-99.1     Press Release                                          1      7K 
 3: EX-99.2     Settlement Agreement                                   5     23K 

8-K   —   Current Report
Document Table of Contents

8-K
1st Page of 3
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------------------

FORM 8-K

CURRENT REPORT

 PURSUANT TO SECTION 13 OR 15 (d) OF
 THE SECURITIES EXCHANGE ACT OF 1934

 Date of Report (Date of earliest event reported): May 3, 2000

----------

 SCHEIN PHARMACEUTICAL, INC.
(Exact name of registrant as specified in its charter)

     Delaware                        1-14019                11-2726505
(State or other jurisdiction of    (Commission file number)   (I.R.S. employer  
incorporation or organization)                               identification no.)

100 Campus Drive, Florham Park, NJ                               07932    
(Address of principal executive offices)                         (Zip code)     

Registrant's telephone number, including area code: (973) 593-5500

8-K
2nd Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 2nd
Item 5.           Other Events                                                  

                  On May 3,  2000,  the  Registrant  issued  the  press  release
attached hereto as Exhibit 99.1. Among other things, the press release announced
that the Registrant  entered into the settlement  agreement  attached  hereto as
Exhibit 99.2.                                                                   

Item 7.       Exhibits                                                          

99.1          Press Release dated May 3, 2000.                                  

99.2          Settlement  Agreement,  dated May 1,  2000,  by and  among  Schein
              Pharmaceutical,  Inc.,  Marvin  H.  Schein,  individually  and  as
              trustee of multiple  trusts created by Mr.  Schein,  and Irving H.
              Shafran,  as trustee  of  multiple  trusts  created by and for the
benefit of Pamela H. Schein.                        

8-K
Last Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 3rd
 SIGNATURE

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.                                           

                               SCHEIN PHARMACEUTICAL, INC.

                                   By: /s/ Whitney K. Stearns, Jr.
                                              ----------------------------------
                                  Name:  Whitney K. Stearns, Jr.
                                          Title: Senior Vice President and Chief
                                   Financial Officer

Date:  May 4, 2000                                                              

Dates Referenced Herein

				Referenced-On Page
This ‘8-K’ Filing		Date		First		Last			Other Filings
Filed on:		5/4/00		3					None on these Dates
For Period End:		5/3/00		1		2
		5/1/00		2
									List all Filings